THERAPEUTIC USE OF THE RETINOBLASTOMA SUSCEPTIBILITY GENE PRODUCT
JOHNSON, DUANE, WANG, NAN, PING, SHEPARD, H., MICHAEL, LEE, WEN-HWA, GOODRICH, DAVID, W, LEE, EVA, Y-H., P
Year of Publication 08.06.1995
Get full text
Year of Publication 08.06.1995
Patent
Therapeutic use of the retinoblastoma susceptibility gene product
WEN-HAW LEE, DUANE JOHNSON, DAVID W GOODRICH, NAN PING WANG, EVA Y-H P LEE, H MICHAEL SHEPARD
Year of Publication 03.05.1995
Get full text
Year of Publication 03.05.1995
Patent
Therapeutic use of the retinoblastoma susceptibility gene product
H. MICHAEL SHEPARD, EVA Y.-H. P LEE, DUANE JOHNSON, DAVID W GOODRICH, NAN PING WANG, WEN-HWA LEE
Year of Publication 03.04.1995
Get full text
Year of Publication 03.04.1995
Patent
THERAPEUTIC USE OF THE RETINOBLASTOMA SUSCEPTIBILITY GENE PRODUCT
JOHNSON, DUANE, WANG, NAN, PING, SHEPARD, H., MICHAEL, LEE, WEN-HWA, GOODRICH, DAVID, W, LEE, EVA, Y-H., P
Year of Publication 23.03.1995
Get full text
Year of Publication 23.03.1995
Patent
Characteristics of two new retinoblastoma cell lines: WERI-Rb24 and WERI-Rb27
Sery, T W, Lee, E Y, Lee, W H, Bookstein, R, Wong, V, Shields, J A, Augsburger, J J, Donoso, L A
Published in Journal of pediatric ophthalmology and strabismus (01.07.1990)
Published in Journal of pediatric ophthalmology and strabismus (01.07.1990)
Get full text
Journal Article
COMPOSICIONES QUE CONTROLAN EL CICLO CELULAR Y PROCEDIMIENTO PARA SU UTILIZACION
LEE, EVA, Y., H., P, LEE, WEN-HWA, GOODRICH, DAVID, W, WANG, NANG-PING
Year of Publication 16.10.2000
Get full text
Year of Publication 16.10.2000
Patent